AstraZeneca Launches New Crestor DTC Ad Campaign

The firm is managing the right level of investment for Crestor, CFO Symonds tells analysts. The statin has a 7.6% share of new prescriptions for the week ending Oct. 8.

More from Archive

More from Pink Sheet